PHILADELPHIA and MALVERN, Pa., June 23, 2025 (GLOBE NEWSWIRE) -- Carisma Therapeutics Inc. (Nasdaq: CARM) (Carisma) and OrthoCellix, Inc. (OrthoCellix), a wholly ...
PHILADELPHIA, May 8, 2024 /PRNewswire/ -- Carisma Therapeutics Inc. (CARM) (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and developing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results